Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 53, 3925-3929, September 1, 1993]
© 1993 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Povoski, S. P.
Right arrow Articles by Bell, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Povoski, S. P.
Right arrow Articles by Bell, R. H., Jr.

Stimulation of Growth of Azaserine-induced Putative Preneoplastic Lesions in Rat Pancreas Is Mediated Specifically by Way of Cholecystokinin-A Receptors1

Stephen P. Povoski, Weigong Zhou, Daniel S. Longnecker, Bill D. Roebuck and Richard H. Bell, Jr.2

Department of Surgery, University of Cincinnati College of Medicine and Veterans Affairs Medical Center, Cincinnati, Ohio 45267 [S. P. P., W. Z., R. H. B.], and Departments of Pathology [D. S. L.] and Pharmacology and Toxicology [B. D. R.], Dartmouth Medical School, Hanover, New Hampshire 03756

Cholecystokinin (CCK) has been shown to stimulate the growth of both normal pancreas and azaserine-induced putative preneoplastic pancreatic lesions in the rat. The present study was performed to determine whether these effects are mediated by way of CCK-A receptors, CCK-B receptors, or both. Sixteen-day-old male Lewis rats were given i.p. injections of azaserine at 30 mg/kg body weight. Starting on day 21, rats were given s.c. injections, 5 days/week for 16 consecutive weeks, of either (a) CCK octapeptide (nonselective CCK agonist) (2.50 µg/kg body weight, n = 17), (b) tert-butyloxycarbonyl-Trp-Lys({varepsilon}-N-2-methylphenylaminocarbonyl)-Asp-(N-methyl)-Phe-NH2 (highly selective CCK-A agonist) (1.84 µg/kg body weight, n = 18), (c) [(2R,3S)-ß-MePhe28,N-MeNle31]CCK26–33 (highly selective CCK-B agonist) (2.40 µg/kg body weight, n = 18), or (d) normal saline solution (control, n = 17). Rats were subsequently sacrificed, pancreatic weights were determined, and quantitative morphometric analysis of atypical acinar cell foci and nodules was performed. Both CCK octapeptide and the selective CCK-A agonist tert-butyloxycarbonyl-Trp-Lys({varepsilon}-N-2-methylphenylaminocarbonyl)-Asp-(N-methyl)-Phe-NH2 stimulated pancreatic growth and the development of acidophilic atypical acinar cell foci and nodules. Furthermore, the effect produced by the selective CCK-A agonist tert-butyloxycarbonyl-Trp-Lys({varepsilon}-N-2-methylphenylaminocarbonyl)-Asp-(N-methyl)-Phe-NH2 was greater than that produced by CCK octapeptide. In contrast, the selective CCK-B agonist [(2R,3S)-ß-MePhe28,N-MeNle31]CCK26–33 had no effect. These findings suggest that the growth of putative preneoplastic lesions (acidophilic atypical acinar cell foci and nodules) in the rat pancreas during the early stages of azaserine-induced pancreatic carcinogenesis is mediated specifically by way of CCK-A receptors.

1 This study was supported by a grant from the Medical Research Service of the Department of Veterans Affairs and a Cancer Research Fellowship (S. P. P.) from the Ohio Division of the American Cancer Society.

2 To whom requests for reprints should be addressed, at Surgical Service (112), Department of Veterans Affairs Medical Center, 3200 Vine St., Cincinnati, OH 45220.

Received 4/ 6/93. Accepted 6/28/93.




This article has been cited by other articles:


Home page
Toxicol SciHome page
L. Dethloff, B. Barr, L. Bestervelt, S. Bulera, R. Sigler, M. LaGattuta, and F. de la Iglesia
Gabapentin-Induced Mitogenic Activity in Rat Pancreatic Acinar Cells
Toxicol. Sci., May 1, 2000; 55(1): 52 - 59.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Singh, A. Owlia, R. Espeijo, and B. Dai
Novel Gastrin Receptors Mediate Mitogenic Effects of Gastrin and Processing Intermediates of Gastrin on Swiss 3T3 Fibroblasts
J. Biol. Chem., April 14, 1995; 270(15): 8429 - 8438.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.